These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 25109259

  • 1. Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome.
    El-Salhy M, Gilja OH, Hausken T.
    Mol Med Rep; 2014 Oct; 10(4):1753-7. PubMed ID: 25109259
    [Abstract] [Full Text] [Related]

  • 2. Stomach antral endocrine cells in patients with irritable bowel syndrome.
    El-Salhy M, Gilja OH, Hatlebakk JG, Hausken T.
    Int J Mol Med; 2014 Oct; 34(4):967-74. PubMed ID: 25110039
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome.
    El-Salhy M, Wendelbo IH, Gundersen D.
    Mol Med Rep; 2013 Apr; 7(4):1241-4. PubMed ID: 23426642
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome.
    El-Salhy M, Mazzawi T, Gundersen D, Hausken T.
    Mol Med Rep; 2012 Dec; 6(6):1223-5. PubMed ID: 22992886
    [Abstract] [Full Text] [Related]

  • 7. Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance.
    Mazzawi T, El-Salhy M.
    Int J Mol Med; 2016 May; 37(5):1247-53. PubMed ID: 26987104
    [Abstract] [Full Text] [Related]

  • 8. Abnormal rectal endocrine cells in patients with irritable bowel syndrome.
    El-Salhy M, Gundersen D, Hatlebakk JG, Gilja OH, Hausken T.
    Regul Pept; 2014 Jan 10; 188():60-5. PubMed ID: 24316398
    [Abstract] [Full Text] [Related]

  • 9. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome.
    El-Salhy M, Gilja OH.
    BMC Gastroenterol; 2017 Aug 01; 17(1):90. PubMed ID: 28764761
    [Abstract] [Full Text] [Related]

  • 10. Endocrine cells in the ileum of patients with irritable bowel syndrome.
    El-Salhy M, Gilja OH, Gundersen D, Hatlebakk JG, Hausken T.
    World J Gastroenterol; 2014 Mar 07; 20(9):2383-91. PubMed ID: 24605036
    [Abstract] [Full Text] [Related]

  • 11. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome.
    El-Salhy M, Lomholt-Beck B, Hausken T.
    Scand J Gastroenterol; 2010 Dec 07; 45(12):1435-9. PubMed ID: 20602602
    [Abstract] [Full Text] [Related]

  • 12. Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome.
    El-Salhy M, Gilja OH, Gundersen D, Hausken T.
    World J Gastrointest Endosc; 2014 May 16; 6(5):176-85. PubMed ID: 24891930
    [Abstract] [Full Text] [Related]

  • 13. Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome.
    El-Salhy M, Patcharatrakul T, Hatlebakk JG, Hausken T, Gilja OH, Gonlachanvit S.
    Scand J Gastroenterol; 2017 May 16; 52(6-7):691-697. PubMed ID: 28346031
    [Abstract] [Full Text] [Related]

  • 14. Density of Musashi‑1‑positive stem cells in the stomach of patients with irritable bowel syndrome.
    El-Salhy M, Hausken T, Hatlebakk JG.
    Mol Med Rep; 2020 Oct 16; 22(4):3135-3140. PubMed ID: 32945509
    [Abstract] [Full Text] [Related]

  • 15. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome.
    El-Salhy M, Vaali K, Dizdar V, Hausken T.
    Dig Dis Sci; 2010 Dec 16; 55(12):3508-13. PubMed ID: 20300845
    [Abstract] [Full Text] [Related]

  • 16. Increased serotonin transporter immunoreactivity intensity in the ileum of patients with irritable bowel disease.
    Wendelbo I, Mazzawi T, El-Salhy M.
    Mol Med Rep; 2014 Jan 16; 9(1):180-4. PubMed ID: 24213511
    [Abstract] [Full Text] [Related]

  • 17. Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease.
    El-Salhy M, Wendelbo I, Gundersen D.
    Mol Med Rep; 2013 Aug 16; 8(2):451-5. PubMed ID: 23778763
    [Abstract] [Full Text] [Related]

  • 18. Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome.
    Mazzawi T, Hausken T, Gundersen D, El-Salhy M.
    Eur J Clin Nutr; 2015 Apr 16; 69(4):519-24. PubMed ID: 25097003
    [Abstract] [Full Text] [Related]

  • 19. Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance.
    Mazzawi T, El-Salhy M.
    Exp Biol Med (Maywood); 2017 Jul 16; 242(13):1355-1362. PubMed ID: 28737477
    [Abstract] [Full Text] [Related]

  • 20. Ghrelin in patients with irritable bowel syndrome.
    El-Salhy M, Lillebø E, Reinemo A, Salmelid L.
    Int J Mol Med; 2009 Jun 16; 23(6):703-7. PubMed ID: 19424595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.